Phibro Animal Health (STU:PB8) Cyclically Adjusted FCF per Share: €0.70 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:PB8 Phibro Animal Health Corp STU:PB8
79 GF Score
Price €29.40
GF Value €26.45
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Phibro Animal Health Cyclically Adjusted FCF per Share?

Phibro Animal Health STU:PB8 -3.92% 79 Cyclically Adjusted FCF per Share is €0.70 as of Mar. 2026. GuruFocus rates STU:PB8 with a GF Score™ of 79/100 and a GF Value™ of €26.45 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Phibro Animal Health's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.019. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.70 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Phibro Animal Health's average Cyclically Adjusted FCF Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Phibro Animal Health was 0.50% per year. The lowest was 0.50% per year. And the median was 0.50% per year.

As of today (2026-08-09), Phibro Animal Health's current stock price is €29.40. Phibro Animal Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.70. Phibro Animal Health's Cyclically Adjusted Price-to-FCF of today is 42.00.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Phibro Animal Health was 71.47. The lowest was 15.84. And the median was 27.87.


Phibro Animal Health  (STU:PB8) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Phibro Animal Health's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=29.40/0.70
=42.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Phibro Animal Health was 71.47. The lowest was 15.84. And the median was 27.87.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Phibro Animal Health Cyclically Adjusted FCF per Share Related Terms


Phibro Animal Health Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Phibro Animal Health's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phibro Animal Health Cyclically Adjusted FCF per Share Chart

Phibro Animal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.65 0.50 0.72 0.60

Phibro Animal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.60 0.60 0.65 0.70

STU:PB8 vs PRGO, HROW, XERS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Cyclically Adjusted Price-to-FCF falls into.


STU:PB8
79GF Score
Phibro Animal Health Corp STU:PB8
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phibro Animal Health Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Phibro Animal Health's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.019/330.2130*330.2130
=0.019

Current CPI (Mar. 2026) = 330.2130.

Phibro Animal Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.422 241.018 0.578
201609 0.347 241.428 0.475
201612 0.512 241.432 0.700
201703 0.753 243.801 1.020
201706 0.179 244.955 0.241
201709 -0.004 246.819 -0.005
201712 0.595 246.524 0.797
201803 0.374 249.554 0.495
201806 0.097 251.989 0.127
201809 -0.101 252.439 -0.132
201812 0.201 251.233 0.264
201903 0.175 254.202 0.227
201906 0.104 256.143 0.134
201909 -0.252 256.759 -0.324
201912 0.526 256.974 0.676
202003 0.427 258.115 0.546
202006 -0.136 257.797 -0.174
202009 -0.120 260.280 -0.152
202012 0.398 260.474 0.505
202103 0.189 264.877 0.236
202106 -0.082 271.696 -0.100
202109 -0.076 274.310 -0.091
202112 0.272 278.802 0.322
202203 -0.087 287.504 -0.100
202206 -0.241 296.311 -0.269
202209 -0.845 296.808 -0.940
202212 -0.287 296.797 -0.319
202303 -0.038 301.836 -0.042
202306 0.213 305.109 0.231
202309 0.202 307.789 0.217
202312 0.466 306.746 0.502
202403 0.038 312.332 0.040
202406 0.352 314.175 0.370
202409 0.067 315.301 0.070
202412 -0.111 315.605 -0.116
202503 0.805 319.799 0.831
202506 0.173 322.561 0.177
202509 -0.094 324.800 -0.096
202512 0.172 324.054 0.175
202603 0.019 330.213 0.019

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.70 mean?
Phibro Animal Health (STU:PB8) has a Cyclically Adjusted FCF per Share of €0.70 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Phibro Animal Health and its competitors.
Is Phibro Animal Health's Cyclically Adjusted FCF per Share too high?
Phibro Animal Health's current Cyclically Adjusted FCF per Share is €0.70. Overall, Phibro Animal Health has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's Cyclically Adjusted FCF per Share compare to PRGO and HROW?
Phibro Animal Health's Cyclically Adjusted FCF per Share of €0.70 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Phibro Animal Health and its competitors. Phibro Animal Health's current Cyclically Adjusted FCF per Share is €0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (STU:PB8) is currently considered Modestly Overvalued. The stock's GF Value™ is €26.45, compared to a current price of €29.40 — trading 11.2% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.70. Phibro Animal Health's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Phibro Animal Health (STU:PB8), the current Cyclically Adjusted FCF per Share is €0.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phibro Animal Health (STU:PB8) Overvalued in 2026?

Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued. The current stock price of €29.40 is trading 11.2% above its estimated GF Value™ of €26.45. GuruFocus considers Phibro Animal Health to be Modestly Overvalued.

Key valuation signals for STU:PB8:

  • Cyclically Adjusted FCF per Share: €0.70
  • GF Value™: €26.45 vs. price of €29.40 (11.2% above fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the STU:PB8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phibro Animal Health Business Description

Other Exchanges PAHC:USA
Address 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
79GF Score

Get the complete analysis for STU:PB8

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.40
Price
€26.45
GF Value